Sage Journals: Discover world-class research

Retricted access

Review article

First published 1999-12

Candesartan Cilexetil: An Angiotensin II Receptor Blocker

Cheryl A Stoukides, Heather J McVoy, Alan F Kaul

Annals of Pharmacotherapy

Retricted access

Research article

First published 2008-10

Candesartan Cilexetil Effectively Reduces Blood Pressure in Hypertensive Children

Amy M Franks, Catherine E O'Brien, Cindy D Stowe [...]

Annals of Pharmacotherapy

Retricted access

Other

First published 2002-09

Antiproteinuric effect of candesartan cilexetil in patients with chronic glomerulonephritis

Kiyoshi Kurokawa, Keishi Abe, Takao Saruta [...]

Journal of the Renin-Angiotensin-Aldosterone System

Retricted access

Research article

First published 2007-9

Oral Bioavailability of Candesartan Cilexetil Suspension

Renli Teng, Anna-Carin Hansson, Inger Börjesson

Journal of Pharmacy Technology

Retricted access

Other

First published 2007-01

Effect of candesartan cilexetil on carotid intima-media thickness in hypertensive type 2 diabetic patients. MITEC study: design and baseline characteristics

Paul Valensi, Jean-Philippe Baguet, Roland Asmar [...]

The British Journal of Diabetes & Vascular Disease

Retricted access

Research article

First published 2000-3

The Safety and Tolerability of Candesartan Cilexetil in CHF

Erland Erdmann, Michael George, Bernhard Voet [...]

Journal of the Renin-Angiotensin-Aldosterone System

Retricted access

Other

First published 2001-3

Persistent effect of treatment with candesartan cilexetil on blood pressure in spontaneously hypertensive rats

Karin Skov, Susie Mogensen, Michael J Mulvany

Journal of the Renin-Angiotensin-Aldosterone System

Retricted access

Other

First published 2003-06

Dual blockade with candesartan cilexetil and lisinopril in hypertensive patients with diabetes mellitus: rationale and design

Niels H Andersen, Søren T Knudsen, Per L Poulsen [...]

Journal of the Renin-Angiotensin-Aldosterone System

Retricted access

Research article

First published 2009-10

Angiotensin II Receptor Blocker Candesartan Cilexetil,but Not Hydralazine Hydrochloride,Protects Against Mouse Cardiac Enlargement Resulting From Undernutrition In Utero

Makoto Kawamura, Hiroaki Itoh, Shigeo Yura [...]

Reproductive Sciences

Free access

Research article

First published 1999-11

Characterization of Hydronephrosis in Neonatal Rats from Dams Receiving Candesartan Cilexetil (TCV-116),an Angiotensin II Type 1 Receptor Antagonist

Yoshimasa Ishimura, Fumio Chatani, Shuzo Sato

International Journal of Toxicology

Search results